VA

Vijay Anand Nithya

Active Director Director DIN 10457193
DIN 10457193 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Vijay Anand Nithya

Data last updated:

Vijay Anand Nithya is a Director at Jacsims Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Jacsims Pharmaceuticals Private Limited reported revenue of ₹94.3 Lakh (FY 2025).

DIN 10457193
Primary Designation Director
Industry Pharma
First Appointment 08 Jan 2024
Oldest Company Age 2 yrs
Largest company Jacsims Pharmaceuticals Private Limited · ₹94.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20242024₹94.3 Lakh (FY 2025)Active

Board colleagues of Vijay Anand Nithya

Directorship timeline

Open interactive timeline →
Jacsims Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vijay Anand Nithya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Anand Nithya

Vijay Anand Nithya currently holds 1 directorship: Jacsims Pharmaceuticals Private Limited (Director, since 08 Jan 2024, revenue ₹94.3 Lakh (FY 2025)).

Vijay Anand Nithya was first appointed on 08 Jan 2024 as Director at Jacsims Pharmaceuticals Private Limited.

The current boards of Vijay Anand Nithya's companies include Balasubramanian Vijay Anand (Jacsims Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available